Policy Roadmap for Medicines Manufacturing Leadership

6 July 2020

Policy

Call for tenders SANTE/2020/C3/29 for the supply of medicinal products used for intensive care patients subject to the novel coronavirus (COVID-19) disease – policy and technical concerns

25 June 2020

Policy

Preparing for a potential second COVID-19 wave. Joint statement by Medicines for Europe and EFPIA with Kearney

22 June 2020

Policy

LESSONS LEARNED FROM COVID-19 – POLICY PAPER

22 June 2020

Policy

Position Paper. Reference safety information: challenges to the generic industry due to labelling harmonisation issues among different Member States

8 May 2020

Policy

Position Paper. Incentives Review The Orphan and Paediatric Incentives

1 March 2020

Policy

The secret to improve access to value added medicines

14 November 2019

Policy

A digital future for value added medicines

24 September 2019

Policy, Report

Positioning Statements on Physician-led Switching for Biosimilar Medicines

19 September 2019

Policy

Positioning Statements on Physician-led Switching for Biosimilar Medicines BIOSIMILAR MEDICINES […]

Open letter to the Members of the European Parliament on the importance to sustain EU progress in fighting against antimicrobial resistance (AMR)

11 September 2019

Policy